Error loading player: No playable sources found
Turning Mandates into Momentum: How CASSS Can Help Sonia Vallabh?
Date
January 30, 2025
This product is not available for individual purchase, but it is available as part of the following products:
General
Related Products
Parallel Session 5B - Immunogenicity Risk and Control
Peptides, proteins and oligonucleotide are becoming essential medical treatments for many progressive, debilitating, or life-threatening diseases. However, the development of these potential therapies can be derailed by product immunogenicity as it can impact on safety and efficacy…
Parallel Session 5A - Integrated Control Strategy for Combination Products
Drug-device combination products such as prefilled syringes, autoinjectors, etc. can play an important role to ensure patient convenience, compliance, and enhance therapeutic impact of the drug…
Plenary Session 4 - Old Dog, New Tricks: Harnessing the Hidden Potential of Established Analytical Technologies to Drive Complex Product Characterization
Innovations in therapeutic modalities are continually emerging as viable treatment options for a multitude of disease indications…
Parallel Session 2B- LER 2025: Strategies Today for Overcoming Low Endotoxin Recovery
Monitoring and control of endotoxin are critical aspects of an overall microbial control strategy necessary to ensure drug product quality and patient safety…
